-
1
-
-
64749110344
-
Hypoglycemia: Still the limiting factor in the glycemic management of diabetes
-
Cryer PE. Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr Pract 2008;14:750-6
-
(2008)
Endocr Pract
, vol.14
, pp. 750-756
-
-
Cryer, P.E.1
-
2
-
-
33748366186
-
Hypoglycemia in type 1 and type 2 diabetes: Physiology, pathophysiology, and management
-
DOI 10.2337/diaclin.24.3.115
-
Briscoe V, Davis S. Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology, and management. Clin Diabetes 2006;24:115-21 (Pubitemid 44338340)
-
(2006)
Clinical Diabetes
, vol.24
, Issue.3
, pp. 115-121
-
-
Briscoe, V.J.1
Davis, S.N.2
-
4
-
-
18144388647
-
Defining and reporting hypoglycemia in diabetes: A report from the american diabetes association workgroup on hypoglycemia
-
American Diabetes Association Workgroup on Hypoglycemia.
-
American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005;28:1245-9
-
(2005)
Diabetes Care
, vol.28
, pp. 1245-1249
-
-
-
5
-
-
77952938468
-
Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes
-
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.
-
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care 2010;33:1004-8
-
(2010)
Diabetes Care
, vol.33
, pp. 1004-1008
-
-
-
6
-
-
20444408424
-
Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: A population-based study
-
DOI 10.1111/j.1464-5491.2005.01501.x
-
Donnelly LA, Morris AD, Frier BM, et al. Frequency and predictors of hypogly-caemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med 2005;22:749-55 (Pubitemid 40805897)
-
(2005)
Diabetic Medicine
, vol.22
, Issue.6
, pp. 749-755
-
-
Donnelly, L.A.1
Morris, A.D.2
Frier, B.M.3
Ellis, J.D.4
Donnan, P.T.5
Durran, R.6
Band, M.M.7
Reekie, G.8
Leese, G.P.9
-
7
-
-
33947704161
-
PREDICTIVE™ - A global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: Baseline characteristics and predictors of hypoglycaemia from the European cohort
-
DOI 10.1111/j.1463-1326.2006.00677.x
-
Luddeke HJ, Sreenan S, Aczel S, et al. PREDICTIVE-a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort. Diabetes Obes Metab 2007;9:428-34 (Pubitemid 46502063)
-
(2007)
Diabetes, Obesity and Metabolism
, vol.9
, Issue.3
, pp. 428-434
-
-
Luddeke, H.-J.1
Sreenan, S.2
Aczel, S.3
Maxeiner, S.4
Yenigun, M.5
Kozlovski, P.6
Gydesen, H.7
Dornhorst, A.8
-
8
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK prospective diabetes study (UKPDS) group
-
UK Prospective Diabetes Study (UKPDS) Group.
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352: 837-53
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
9
-
-
0034912477
-
Hypoglycemia in patients with type 2 diabetes mellitus
-
Miller CD, Phillips LS, Ziemer DC, et al. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001;161:1653-9 (Pubitemid 32681147)
-
(2001)
Archives of Internal Medicine
, vol.161
, Issue.13
, pp. 1653-1659
-
-
Miller, C.D.1
Phillips, L.S.2
Ziemer, D.C.3
Gallina, D.L.4
Cook, C.B.5
El-Kebbi, I.M.6
-
10
-
-
43449094999
-
Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in france
-
Vexiau P, Mavros P, Krishnarajah G, et al. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes Obes Metab 2008;10(1 Suppl):16-24
-
(2008)
Diabetes Obes Metab
, vol.10
, Issue.1 SUPPL.
, pp. 16-24
-
-
Vexiau, P.1
Mavros, P.2
Krishnarajah, G.3
-
11
-
-
25444502935
-
Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes
-
DOI 10.1185/030079905X61929, 3146
-
Davis RE, Morrissey M, Peters JR, et al. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005; 21:1477-83 (Pubitemid 41368581)
-
(2005)
Current Medical Research and Opinion
, vol.21
, Issue.9
, pp. 1477-1483
-
-
Davis, R.E.1
Morrissey, M.2
Peters, J.R.3
Wittrup-Jensen, K.4
Kennedy-Martin, T.5
Currie, C.J.6
-
12
-
-
0026084950
-
Symptomatic hypoglycaemia in 411 type 1 diabetic patients
-
Pramming S, Thorsteinsson B, Bendtson I, et al. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991;8:217-22
-
(1991)
Diabet Med
, vol.8
, pp. 217-222
-
-
Pramming, S.1
Thorsteinsson, B.2
Bendtson, I.3
-
13
-
-
80052455283
-
The impact of non-severe hypo-glycemic events on work productivity and diabetes management
-
Brod M, Christensen T, Thomson TL, et al. The impact of non-severe hypo-glycemic events on work productivity and diabetes management. Value Health 2011;14:665-71
-
(2011)
Value Health
, vol.14
, pp. 665-671
-
-
Brod, M.1
Christensen, T.2
Thomson, T.L.3
-
14
-
-
0041592733
-
Hypoglycemia in diabetes
-
DOI 10.2337/diacare.26.6.1902
-
Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003;26:1902-12 (Pubitemid 36929141)
-
(2003)
Diabetes Care
, vol.26
, Issue.6
, pp. 1902-1912
-
-
Cryer, P.E.1
Davis, S.N.2
Shamoon, H.3
-
15
-
-
72449165113
-
Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis
-
Davidson JA, Liebl A, Christiansen JS, et al. Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis. Clin Ther 2009; 31:1641-51
-
(2009)
Clin Ther
, vol.31
, pp. 1641-1651
-
-
Davidson, J.A.1
Liebl, A.2
Christiansen, J.S.3
-
16
-
-
1442310505
-
Nocturnal hypoglycemia: Clinical manifestations and therapeutic strategies toward prevention
-
Allen KV, Frier BM. Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention. Endocr Pract 2003;9:530-43
-
(2003)
Endocr Pract
, vol.9
, pp. 530-543
-
-
Allen, K.V.1
Frier, B.M.2
-
17
-
-
0029062779
-
Nocturnal hypoglycaemia in patients with insulin-dependent diabetes mellitus
-
Bendtson I. Nocturnal hypoglycaemia in patients with insulin-dependent diabetes mellitus. Dan Med Bull 1995;42:269-84
-
(1995)
Dan Med Bull
, vol.42
, pp. 269-284
-
-
Bendtson, I.1
-
18
-
-
80053047636
-
How diabetes and insulin therapy affects the lives of people with type 1 diabetes
-
Nafees B, Lloyd A, Kennedy-Martin T, et al. How diabetes and insulin therapy affects the lives of people with type 1 diabetes. Eur Diabetes Nursing 2006; 3:92-7
-
(2006)
Eur Diabetes Nursing
, vol.3
, pp. 92-97
-
-
Nafees, B.1
Lloyd, A.2
Kennedy-Martin, T.3
-
19
-
-
0242516067
-
Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: Reduced awakening from sleep during hypoglycemia
-
DOI 10.2337/diabetes.52.5.1195
-
Banarer S, Cryer PE. Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes 2003;52:1195-203 (Pubitemid 36523356)
-
(2003)
Diabetes
, vol.52
, Issue.5
, pp. 1195-1203
-
-
Banarer, S.1
Cryer, P.E.2
-
20
-
-
0031935612
-
Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM
-
DOI 10.2337/diacare.21.3.341
-
King P, Kong MF, Parkin H, et al. Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM. Diabetes Care 1998;21:341-5 (Pubitemid 28101066)
-
(1998)
Diabetes Care
, vol.21
, Issue.3
, pp. 341-345
-
-
King, P.1
Kong, M.-F.2
Parkin, H.3
Macdonald, I.A.4
Tattersall, R.B.5
-
21
-
-
66249118999
-
Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: The ISPOR patient-reported outcomes translation and linguistic validation good research practices task force report
-
Wild D, Eremenco S, Mear I, et al. Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR patient-reported outcomes translation and linguistic validation good research practices task force report. Value Health 2009;12:430-40
-
(2009)
Value Health
, vol.12
, pp. 430-440
-
-
Wild, D.1
Eremenco, S.2
Mear, I.3
-
23
-
-
84856025095
-
-
The World Factbook Washington, D.C.: Central Intelligence Agency Available at Accessed March 22, 2010
-
The World Factbook. Europe: United Kingdom. Washington, D.C.: Central Intelligence Agency, 2009; Available at: https://www.cia.gov/library/ publications/the-world-factbook/geos/uk.html. Accessed March 22, 2010
-
(2009)
Europe: United Kingdom
-
-
|